Mirae Asset Global Investments Co. Ltd. Grows Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,608 shares of the company’s stock after purchasing an additional 1,093 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in HCA Healthcare were worth $7,504,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare in the 2nd quarter valued at about $28,000. Bangor Savings Bank increased its stake in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC lifted its position in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

NYSE HCA opened at $356.63 on Tuesday. The stock has a 50-day moving average of $394.71 and a two-hundred day moving average of $352.94. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a 1-year low of $222.23 and a 1-year high of $417.14. The company has a market cap of $93.41 billion, a P/E ratio of 17.78, a P/E/G ratio of 1.52 and a beta of 1.67.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Analyst Ratings Changes

A number of research firms have recently issued reports on HCA. Barclays upped their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Truist Financial raised their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Royal Bank of Canada increased their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. KeyCorp dropped their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday. Finally, Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $379.11.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.